Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanni Zhu

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Antiviral Therapy|July 5, 2016
Efficacy of sofosbuvir plus ribavirin in treatment-naive patients with genotype-1 and -3 HCV infection: results from a Russian Phase IIIb studyVasily Isakov, Konstantin Zhdanov, Kathryn Kersey, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|January 27, 2022
Fractional microneedle radiofrequency device and fractional erbium-doped glass 1,565-nm device treatment of human facial photoaging: a prospective, split-face, random clinical trialWenjie Dou, Qing Yang, Yue Yin, et al.
Molecular Cancer|January 6, 2024
N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulationHan Li, Run Lin, Yanna Zhang, et al.
Medicine|May 24, 2020
Prevalence and causes of visual impairment in population more than 50 years old: The Shaanxi Eye StudyYuan He, Aiping Nie, Jinzhi Pei, et al.
Micromachines|June 27, 2024
Efficient Quasi-Two-Dimensional Perovskite Light-Emitting Diodes Achieved through the Passivation of Multi-Fluorine Phosphate MoleculesPeiding Li, Chunyu Wei, He Dong, et al.
Hepatology (Baltimore, Md.)|April 8, 2015
Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimensDavid Wyles, Paul Pockros, Giuseppe Morelli, et al.
NPJ Breast Cancer|July 9, 2024
Author Correction: Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancerSara A Hurvitz, Aditya Bardia, Kevin Punie, et al.
NPJ Breast Cancer|April 25, 2024
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancerSara A Hurvitz, Aditya Bardia, Kevin Punie, et al.
Frontiers in Medicine|April 23, 2026
Advantages of optical coherence tomography in assessing retinal astrocytic hamartomas in children with tuberous sclerosis complexGuorui Dou, Ziyi Zhou, Jiaxing Sun, et al.
Hepatology (Baltimore, Md.)|December 26, 2015
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or olderSammy Saab, Sarah H Park, Masashi Mizokami, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Antiviral Therapy|July 5, 2016
Efficacy of sofosbuvir plus ribavirin in treatment-naive patients with genotype-1 and -3 HCV infection: results from a Russian Phase IIIb studyVasily Isakov, Konstantin Zhdanov, Kathryn Kersey, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|January 27, 2022
Fractional microneedle radiofrequency device and fractional erbium-doped glass 1,565-nm device treatment of human facial photoaging: a prospective, split-face, random clinical trialWenjie Dou, Qing Yang, Yue Yin, et al.
Molecular Cancer|January 6, 2024
N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulationHan Li, Run Lin, Yanna Zhang, et al.
Medicine|May 24, 2020
Prevalence and causes of visual impairment in population more than 50 years old: The Shaanxi Eye StudyYuan He, Aiping Nie, Jinzhi Pei, et al.
Micromachines|June 27, 2024
Efficient Quasi-Two-Dimensional Perovskite Light-Emitting Diodes Achieved through the Passivation of Multi-Fluorine Phosphate MoleculesPeiding Li, Chunyu Wei, He Dong, et al.
Hepatology (Baltimore, Md.)|April 8, 2015
Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimensDavid Wyles, Paul Pockros, Giuseppe Morelli, et al.
NPJ Breast Cancer|July 9, 2024
Author Correction: Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancerSara A Hurvitz, Aditya Bardia, Kevin Punie, et al.
NPJ Breast Cancer|April 25, 2024
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancerSara A Hurvitz, Aditya Bardia, Kevin Punie, et al.
Frontiers in Medicine|April 23, 2026
Advantages of optical coherence tomography in assessing retinal astrocytic hamartomas in children with tuberous sclerosis complexGuorui Dou, Ziyi Zhou, Jiaxing Sun, et al.
Hepatology (Baltimore, Md.)|December 26, 2015
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or olderSammy Saab, Sarah H Park, Masashi Mizokami, et al.
Pageof 5